Cuhkhaswontwonationalscienceandtechnologyawardsforitsstroke.Smotreekam(fourthfromright)andtheguangdongpeople&39;shospitalprofessorWuYilongteamof(in)andsoon,bythe"lungcancermoleculartargetaccuratetreatmentmodelestablishmentandapplicationof"wasawardedthesecondprizeofnationalscienceandtechnologyprogress.Thesepharmaceuticaldistributioncompanieshavewell-trainedstaff,coordinatingwithwhomisverysystematic.CuhkforfigureHongKongdailynews(reporterGaoYu)2017annualnationalscienceandtechnologyawardsconferencerecentlyheldinBeijinggreathallofthepeople,theChineseuniversityhasparticipatedinthe"lungcancermoleculartargetmodelestablishmentandapplicationofprecisetreatment"and"preventionofischemiccerebralapoplexy&39;snewstrategyandnewtechnologyandapplication"projectwasawardedthesecondprizeofnationalscienceandtechnologyprogress.Theanti-cancermechanismisexpectedtobe"nolongerfatal"Cuhkmedicalschoolofthedepartmentoftumor,themotreebrocadeandguangdongprovincepeople&39;shospitalprofessorWuYilongteammainforcecomposedoflungcancerresearch,especiallyfortheepidermalgrowthfactorreceptor(EGFR)genevariantsoflungadenocarcinoma,eventuallycreatedthe"targettreatment"mode,extendsurvivalperiodfrom10monthsto22months.TeamalsofoundthatEGFRonformationofsecondarygenemutationandresistantmechanismofcarcinogenicfactorcancausecancer,accordingtoanewgenemutationandresistanceofpatients.theteamfoundanewaccuratetreatmentplancanbenoworsesurvivaltimeeffectivelyextendmorethandoubled.TheresearchfindingsareincludedintheguidelinesforthediagnosisandtreatmentoflungcancerinChinaandaroundtheworld.Itisexpectedthatfuturelungcancerwillnotbeafataldisease,butachronicdiseasethatcanbetreatedwithdrugs.Departmentofinternalmedicineanddrugtreatment,schoolofmedicine,cuhk,honoraryclinicalprofessorwongkasingLawrence,inconjunctionwiththeChinesepeople&39;sliberationarmythirdmilitarymedicaluniversityandchongqingmedicaluniversityteamcomposedofexpertssuchasinthestudyonthepreventionandtreatmentofstroke.WongkasingLawrence,accordingtoresearchinprinceofwaleshospitalconfirmedcerebrovascularnarrowingChineseisamaincauseofstroke,andadoptsdualantiplatelettherapy,andhorsespiritaloneismoreeffectivetoreduce"transientischemic"problemofmicroemboliandmildstrokepatients.Twonewmethodsimprovestrokesymptoms.Inrecentyears,wongkasingLawrenceteamalsofoundthat"law"ecpcanimprovecerebralbloodsupplyinpatientswithstroke,while"brainmagneticshocktreatment"byreconnectingthedamagetothebrainandbodychannel,abilitytohelppatientsrecoveryactivities.Wongsaidhehopedthenewapproachwouldbringlighttopeoplesufferingfromstroke.Theoriginaladdress:http://paper.wenweipo.com/2018/01/19/ED1801190007.htm
